Bioactive Products
A unique collection of 184 natural compounds used for Antibacterial research. | ||
Catalog No: | Bb192 | Antibacterial Compound Library Screening Details |
Size: | 1mg/well * 184 Compounds 2mg/well * 184 Compounds |
Cat. No. | Information |
CFN00140 | Tirandalydigin Tirandalydigin is a new tetramic acid antibiotic, it has MICs in the range of 0.5 to 32 micrograms/ml against many pathogenic anaerobes, streptococci, enterococci and legionellae. |
CFN00142 | Tirandamycin B Tirandamycin B is a BmAsnRS inhibitor, it is a leading anti-filarial drug . Tirandamycin B has antitumor and antibacterial activities. |
CFN00143 | Vermisporin Vermisporin, a new antibiotic produced by fermentation of the fungus ophiobolus vermisporis. Vermisporin has antimicrobial activity, which MICs for enterobacteriaceae, pseudomonas aeruginosa and haemophilus influenzae exceeds 64 micrograms/ml; which MBCs is 16- to 32-fold above the MICs. |
CFN00145 | Zopfiellamide A Zopfiellamide A and Zopfiellamide B are antimicrobial metabolites. |
CFN98918 | Galangin Galangin is an agonist/antagonist of the arylhydrocarbon receptor, and also shows inhibition of CYP1A1 activity. Galangin has anti-proliferation, anti-metastatic, anti-inflammatory, vasorelaxant, antiviral, anti-allergic inflammatory,anti-obesity effects; it may be a potential candidate for the treatment of vitiligo. Galangin can inhibit Topo I activity and reduce the unwinding rate of single stranded DNNA in tumor cells, which plays an important role in induction of A549 and H46 cell apoptosis. Galangin shows an inhibitory effect on acetylcholinesterase (AChE) activity with the IC(50) of 120 microM; it also inhibits ERK, NF-κB-p65 and proinflammatory gene expression. |